New York, United States, Fri, 28 Aug 2020 03:29:23 / Comserve Inc. / -- The amphetamine drug market is anticipated to record a robust CAGR during the forecast period, i.e. 2020-2028.

Research Nester released a report titled "Amphetamine Drug Market – Global Demand Analysis & Opportunity Outlook 2028" which delivers a detailed overview of the amphetamine drug market in terms of market segmentation by application, by demography, by distribution channel, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis, and Porter's five force model.

The amphetamine drug market is segmented by application, by demography, by distribution channel, and by region. Based on the application, the amphetamine drug market is segmented into ADHD, narcolepsy, obesity, depression, and others, out of which the depression segment is anticipated to dominate the market owing to the increase in the prevalence of depression among adults and children around the world. On the basis of demographics, the amphetamine drug market has been bifurcated into children and adults. Among the demographic segment, the adult is anticipated to hold the largest share in the market attributed to a large adult patient population. The amphetamine drug market is anticipated to record a robust CAGR during the forecast period, i.e. 2020-2028. This market is thriving on the back of a rising number of ADHD patients and governments' approvals and initiatives to address the health related problems. Along with this, the investments into healthcare system for the betterment of the society further are anticipated to raise the market growth. According to the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA), in 2015, there were 17.2 million individuals who used stimulants, of which 1.8 million were youth and 4.9 million were adults.Request Here For Sample Copy

"The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market)."

Based on the regional analysis, the amphetamine drug market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in North America region is anticipated to dominate the global market and accounted for rising prevalence in the number of depression and ADHD patients globally. Additionally, the continuous focus of key market players is on the consumers, encouraging them to innovate in the market. Such factors are anticipated to boost the market growth of the region. The market in Europe is anticipated to hold the second-largest share owing to the presence of massive pharmaceutical firms in the region

The increasing number of ADHD patients worldwide

According to the survey done by the Centers for Disease Control and Prevention (CDC), 2016, 0.388 million children aged 2–5 years, 4 million children aged 6–11 years, and 3 million children aged 12–17 years, were diagnosed with ADHD in the U.S.

The global surge in the number of incidences is associated with ADHD due to the dearth of established treatment for this disorder. People are left with long-running medication procedures for their treatment. The medicinal treatment through CNS stimulants such as amphetamine is the most preferred way to treat the patient. This is expected to incite the growth of the global amphetamine drug market. However, the side-effects and contraindications related to amphetamine drugs are some of the factors that are estimated to limit market growth. Download a PDF copy of this report:

"The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market)."

For more information, please contact:

Research Nester
Email: [email protected]
Tel: +1-6465869123